This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Nano Hesgarsazan Salamat Arya, Other. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
2 out of 834,453 Years Active: 2021-2025
Title: Innovations of Mohammad Reza Ghaderinia: Pioneering Cancer and COVID-19 Solutions
Introduction
Mohammad Reza Ghaderinia, a prominent inventor based in Tehran, Iran, has made significant contributions to the fields of oncology and infectious disease diagnosis. He holds three patents, showcasing his dedication to developing innovative solutions for pressing health challenges.
Latest Patents
One of Ghaderinia's latest patents focuses on the deactivation of circulating tumor cells (CTCs) in the bloodstream through electrostatic stimulation. This method effectively reduces the viability of these cancerous cells by applying a positive electrostatic field to the bloodstream of cancer patients. Another remarkable patent is a diagnostic method for detecting COVID-19 infections. This method comprises several steps, including drawing blood samples from suspected COVID-19 patients and analyzing the blood serum using electrochemical impedance spectroscopy (EIS) to determine the presence of the virus.
Career Highlights
Throughout his career, Mohammad Reza Ghaderinia has worked with notable companies such as Nano Hesgarsazan Salamat Arya. His expertise and innovative approaches in research have positioned him as a key figure in his domain, improving diagnostic and treatment methods for critical diseases.
Collaborations
Ghaderinia has collaborated with esteemed professionals, including Mohammad Abdolahad and Mohammad Ali Khayamian. Together, they have contributed to the advancement of medical technologies, particularly in the diagnosis and treatment of cancer and viral infections.
Conclusion
Mohammad Reza Ghaderinia's contributions to medical innovations highlight the impact of inventive thinking on healthcare. His patents in deactivating cancer cells and diagnosing COVID-19 are significant advancements that demonstrate his commitment to improving patient outcomes. As he continues to innovate, Ghaderinia is poised to make further contributions to the fields of medicine and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile